HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Nutrition & Obesity Medicine
Meta-analysis
Mazdutide reduces percentage body weight by 12.42% in non-diabetic adults with obesity across five RCTs
Mazdutide helps people with obesity lose weight, analysis finds
This meta-analysis of five randomized controlled trials evaluated mazdutide in non-diabetic adults with obesity. The pooled analysis showed …
A new analysis of five trials finds the drug mazdutide leads to significant weight loss in people with obesity.
Jun 1, 2026
Drug Pipeline
RCT
Mazdutide monotherapy reduces HbA1c and promotes weight loss in Chinese adults with type 2 diabetes over 48 weeks
New Drug Lowers Sugar and Shrinks Weight in Diabetes
This phase 3 randomized controlled trial evaluated weekly subcutaneous mazdutide (4 mg or 6 mg) versus placebo in Chinese adults with type 2…
A new diabetes drug called mazdutide lowers blood sugar and shrinks weight in adults who struggle with diet and exercise alone.
Nat Med
Apr 16, 2026